| Literature DB >> 31070147 |
Jutang Babat Ain Tiewsoh1, Beena Antony1, Rekha Boloor1.
Abstract
Introduction: Human immunodeficiency virus (HIV) belongs to the Genus Lentiviruses and is made up of two main types HIV-1 and HIV-2 which are the causative agents of acquired immune deficiency syndrome (AIDS). It is well documented that HIV-1 infection is predominantly found, but HIV-2 infection has also been detected occasionally now and then. Objective: The objective of this study is to determine the seroprevalence of HIV-2 and dual infection in HIV-infected individuals along with the clinical presentation, co-infections, laboratory profile, and outcome of these patients. Materials andEntities:
Keywords: Acquired immuno deficiency syndrome; human immunodeficiency virus; national acquired immune deficiency syndrome control organization; nonnucleoside reverse transcriptase inhibitor
Mesh:
Substances:
Year: 2019 PMID: 31070147 PMCID: PMC6521635 DOI: 10.4103/aam.aam_23_18
Source DB: PubMed Journal: Ann Afr Med ISSN: 0975-5764
Figure 1The age-wise group distribution of human immunodeficiency virus-1, human immunodeficiency virus-2 and dual infection (human immunodeficiency virus-1 and human immunodeficiency virus-2)
The sociodemographic pattern, history, co-infections, laboratory investigations, and outcome of Human immunodeficiency virus-2 or dual-infected patients
| Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | Case 9 | |
|---|---|---|---|---|---|---|---|---|---|
| Age | 51 | 67 | 58 | 39 | 48 | 58 | 50 | 50 | 42 |
| Sex | Male | Male | Female | Male | Male | Male | Male | Male | Male |
| Days hospitalised | 6 | 2 | 4 | 13 | 14 | 8 | 7 | 5 | 6 |
| Address | Mangalore | Kasaragod | Kasaragod | Chikmangalur | Mangalore | Karkal | Kundapura | Mangalore | Beltangadi |
| Known case of HIV | No | Yes | No | Yes | No | No | Yes | Yes | No |
| On ART treatment | No | Yes | No | No | No | No | No | Yes | No |
| HIV 2/1 and 2 | HIV 2 | HIV 2 | HIV 1 and 2 | HIV 2 | HIV 1 and 2 | HIV 2 | HIV 2 | HIV 2 | HIV 1 and 2 |
| Pulmonary TB | No | No | No | No | No | No | No | Yes | No |
| Extrapulmonary TB | No | No | No | Yes | No | No | Yes | Yes | Yes |
| DOTS treatment | No | No | No | CAT 1 | No | No | CAT 1 | CAT 2 | CAT 1 |
| Oral candidiasis | No | No | No | Yes | No | No | No | Yes | No |
| CD 4 count | NA | NA | NA | 55 | NA | NA | NA | 374 | NA |
| Plasma glucose random (74-140 mg/dl) | 88 | 111 | 112 | 188 | 80 | 162 | 157 | 108 | 144 |
| ESR (upto 10 mm/1st h) | 22 | NA | 54 | 60 | 3 | 109 | 80 | 98 | 31 |
| Hb (>11.5 g/dl) | 11.7 | 10.3 | 10.8 | 11.7 | 15.7 | 10.4 | 7.4 | 10.9 | 13.6 |
| TLC (4000-11,000/cumm) | 3100 | 7300 | 5300 | 7700 | 8000 | 5500 | 6700 | 2700 | 8400 |
| Platelet count (150,000-500,000/cumm) | 215,000 | NA | NA | 430,000 | 228,000 | 310,000 | 301,000 | 261,000 | 226,000 |
| LFT | WNL | WNL | WNL | WNL | WNL | WNL | WNL | WNL | WNL |
| KFT | WNL | WNL | WNL | WNL | WNL | WNL | WNL | WNL | WNL |
| Blood culture | NS | NS | NS | Sterile | NS | NS | NS | NS | |
| Outcome | Improved | Improved | Improved | Improved | Improved | Improved | Improved | LAMA | LAMA |
LAMA=Left against medical advice, WNL=Within normal limit, DOTS=Directly observed treatment, short-course, CAT=Category, NA=Not available, HIV=Human immunodeficiency virus, NS=Not sent, ESR=Erythrocyte sedimentation rate, Hb=Haemoglobin, TB=Tuberculosis, TLC=Total lymphocyte count, ART=Antiretroviral treatment, KFT=Kidney function test, LFT=Liver function test
Fluid analysis of patients with extra-pulmonary tuberculosis (2 cerebrospinal fluid and 1 Ascitic fluid)
| Normal values | Sample | Glucose | Protein | LDH | Adenosine deaminase | Total cell count | Lymphocytes (%) | Neutrophils (%) |
|---|---|---|---|---|---|---|---|---|
| 40-70 mg/dl | 15-45 mg/dl | Up to 0 IU/L | Up to 10 IU/L | |||||
| Case 4 | CSF | 101 | 432.6 | 170 | 12.2 | 235 | 65 | 35 |
| Case 7 | Ascitic fluid | NA | NA | NA | 60.12 | 1300 | 55 | 45 |
| Case 9 | CSF | 46 | 1675.3 | 303 | 110.9 | 224 | 95 | 5 |
CSF=Cerebrospinal fluid, NA=Not available, LDH=Lactate dehydrogenase
The prevalence of human immunodeficiency virus-1, human immunodeficiency virus-2, and dual infection among human immunodeficiency virus-infected individuals in comparison with other studies
| Year published | Country | Population studied | Number of HIV positives included | Percentage of HIV 1 ( | Percentage of HIV 2 ( | Percentage of HIV 1 and 2 ( | Male: female ratio | Age >30 years (%) | |
|---|---|---|---|---|---|---|---|---|---|
| Kannangai | 2003 | South India | General | 1700 | 97.53 (1658) | 2.06 (35) | 0.41 (7) | - | - |
| Kashyap | 2010 | New Delhi, India | General | 1945 | 99.64 (1938) | 0.3 (6) | 0.05 (1) | 6:0 | 5/7 (71.42) |
| Sonth | 2010 | Bagalkot, South India | Blood donors | 350 | 86.85 (304) | 13.15 (46) | - | 4.75:1 | 18/46 (39.1) |
| Takodar | 2013 | Pune, India | General | 242 | 96.7 (234) | 1.65 (4) | 1.65 (4) | - | - |
| Ingole | 2013 | Mumbai, India | General | 5235 | 97.12 (5084) | 1.83 (96) | 1.05 (55) | - | - |
| Sabharwal | 2014 | Jaipur, North India | General | 135 | 99.25 (134) | 0.75 (1) | (0) | - | - |
| Present study | Mangalore, South India | General | 214 | 95.8 (205) | 2.8 (6) | 1.4 (3) | 8:1 | 9/9 (100) |
HIV=Human immunodeficiency virus